Literature DB >> 9442220

Intramedullary spinal cord tumour associated with neurofibromatosis type 1.

T Yagi1, K Ohata, M Haque, A Hakuba.   

Abstract

We investigated the characteristic features of intramedullary spinal cord tumour associated with neurofibromatosis type 1 (NF-1). We have experienced 44 cases of pathologically confirmed intramedullary spinal cord tumour. Diagnosis of NF-1 was done according to the criteria set by the National Institute of Health Consensus Development Conference. Within the described population NF-1 was diagnosed in two patients. Both the patients were male and histopathologically the tumours were anaplastic astrocytoma and glioblastoma multiforme respectively. 6 cases of NF-1 associated with intramedullary spinal cord tumour based on the above diagnostic criteria have so far been reported, including our 2 cases. Of these 6 cases, 5 were male and in one sex was not described. The tumour was an astrocytoma in all 6 cases. This finding suggested that intramedullary spinal cord tumour associated with NF-1 tends to occur predominantly in males and that histopathologically the tumour is likely to be an astrocytoma. We conclude that the criteria proposed by the National Institute of Health Consensus Development Conference are contributory in making an accurate pre-operative pathological diagnosis of intramedullary spinal cord tumour associated with NF-1.

Entities:  

Mesh:

Year:  1997        PMID: 9442220     DOI: 10.1007/bf01411560

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  8 in total

Review 1.  Genetic basis of intramedullary spinal cord tumors and therapeutic implications.

Authors:  A T Parsa; A J Fiore; P C McCormick; J N Bruce
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

Review 2.  Spinal manifestations of Neurofibromatosis type 1.

Authors:  Ben Shofty; Ori Barzilai; Morsi Khashan; Zvi Lidar; Shlomi Constantini
Journal:  Childs Nerv Syst       Date:  2020-06-20       Impact factor: 1.475

3.  Intramedullary spinal cord astrocytoma in adults: postoperative outcome.

Authors:  M S Kim; C K Chung; G Choe; I H Kim; H J Kim
Journal:  J Neurooncol       Date:  2001-03       Impact factor: 4.130

4.  Molecular characterization reveals NF1 deletions and FGFR1-activating mutations in a pediatric spinal oligodendroglioma.

Authors:  Amy K Bruzek; Andrew H Zureick; Paul E McKeever; Hugh J L Garton; Patricia L Robertson; Rajen Mody; Carl J Koschmann
Journal:  Pediatr Blood Cancer       Date:  2016-11-10       Impact factor: 3.167

Review 5.  Spinal cord tumours: advances in genetics and their implications for treatment.

Authors:  Patricia L Zadnik; Ziya L Gokaslan; Peter C Burger; Chetan Bettegowda
Journal:  Nat Rev Neurol       Date:  2013-03-26       Impact factor: 42.937

Review 6.  Intramedullary Spinal Cord Tumors: Part I-Epidemiology, Pathophysiology, and Diagnosis.

Authors:  Dino Samartzis; Christopher C Gillis; Patrick Shih; John E O'Toole; Richard G Fessler
Journal:  Global Spine J       Date:  2015-03-31

7.  Dumbbell-shaped neurofibroma of the upper thoracic spine: A case report.

Authors:  S Ashok Kumar; Manoj Kumar; Monika Malgonde
Journal:  South Asian J Cancer       Date:  2013-10

8.  Genomic Landscape of Intramedullary Spinal Cord Gliomas.

Authors:  Ming Zhang; Rajiv R Iyer; Tej D Azad; Qing Wang; Tomas Garzon-Muvdi; Joanna Wang; Ann Liu; Peter Burger; Charles Eberhart; Fausto J Rodriguez; Daniel M Sciubba; Jean-Paul Wolinsky; Ziya Gokaslan; Mari L Groves; George I Jallo; Chetan Bettegowda
Journal:  Sci Rep       Date:  2019-12-10       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.